Understanding the unique characteristics of seasonal influenza illness to improve vaccine uptake in the US
- PMID: 30366802
- DOI: 10.1016/j.vaccine.2018.10.027
Understanding the unique characteristics of seasonal influenza illness to improve vaccine uptake in the US
Abstract
Seasonal influenza results in substantial morbidity, mortality and socio-economic burden. The US Advisory Committee on Immunization Practices recommends vaccination of everyone over 6 months of age, but coverage remains substantially below the Healthy People 2020 target of 70% in most age groups. Influenza is different from other vaccine-preventable diseases in several ways that influence vaccine uptake. Although the incidence of most vaccine-preventable diseases is low, there is a perception that these diseases result in significant illness or death. In contrast, seasonal influenza has a relatively high incidence, but there is an incorrect perception of a lower disease severity. The vaccine effectiveness of seasonal influenza vaccines is less than other routine vaccines, varies from season to season between northern and southern hemispheres, and can be low in some seasons. It is also not well recognized that vaccination can attenuate the severity of influenza illness. Finally, the need for annual vaccination is perceived as a burden to busy people. Understanding these differences from the perspective of caregivers and vaccinees might help to improve influenza vaccine uptake. Presenting vaccine effectiveness in terms of clinical outcomes that have the most impact might help to overcome the perceptions that influenza is a non-serious disease and that the vaccine is not effective. The benefits of disease attenuation need to be emphasized in terms of reduced mortality, hospitalization, absenteeism and disruption to daily life. Innovative communication strategies should be adopted, including stronger recommendations from and to healthcare providers, continuous patient education, and social media initiatives employing more emotional and narrative approaches than traditionally used. Finally, access to seasonal influenza vaccination needs to be improved, and barriers such as cost and inconvenience removed. Multiple initiatives have already been successful. The remaining challenge is to translate individual successes into public health policies with corresponding funding and implementation.
Keywords: Attenuation; Disease severity; Influenza; Uptake; Vaccine; Vaccine effectiveness.
Copyright © 2018 GlaxoSmithKline Biologicals SA. Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
Evaluation of the impact of immunization policies, including the addition of pharmacists as immunizers, on influenza vaccination coverage in Nova Scotia, Canada: 2006 to 2016.BMC Public Health. 2018 Jun 26;18(1):787. doi: 10.1186/s12889-018-5697-x. BMC Public Health. 2018. PMID: 29940903 Free PMC article.
-
Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany.BMC Public Health. 2012 Oct 31;12:938. doi: 10.1186/1471-2458-12-938. BMC Public Health. 2012. PMID: 23113995 Free PMC article.
-
Influenza vaccination in the Americas: Progress and challenges after the 2009 A(H1N1) influenza pandemic.Hum Vaccin Immunother. 2016 Aug 2;12(8):2206-2214. doi: 10.1080/21645515.2016.1157240. Epub 2016 May 19. Hum Vaccin Immunother. 2016. PMID: 27196006 Free PMC article.
-
Challenges in adult vaccination.Ann Med. 2018 May;50(3):181-192. doi: 10.1080/07853890.2017.1417632. Epub 2018 Jan 16. Ann Med. 2018. PMID: 29338438 Review.
-
Influenza in Latin America: A report from the Global Influenza Initiative (GII).Vaccine. 2019 May 6;37(20):2670-2678. doi: 10.1016/j.vaccine.2019.03.081. Epub 2019 Apr 8. Vaccine. 2019. PMID: 30975568 Review.
Cited by
-
Behavioural and Cognitive Attitudes of Paediatricians towards Influenza Self-Vaccination-Partial Mediation Model.Vaccines (Basel). 2022 Jul 29;10(8):1206. doi: 10.3390/vaccines10081206. Vaccines (Basel). 2022. PMID: 36016094 Free PMC article.
-
Coronavirus disease 2019 (COVID-19) Versus Influenza in Hospitalized Adult Patients in the United States: Differences in Demographic and Severity Indicators.Clin Infect Dis. 2021 Dec 16;73(12):2240-2247. doi: 10.1093/cid/ciab123. Clin Infect Dis. 2021. PMID: 34050659 Free PMC article.
-
Seasonal Influenza Vaccination and Recommendation: The Difference between General Practitioners and Public Health Workers in China.Vaccines (Basel). 2020 May 31;8(2):265. doi: 10.3390/vaccines8020265. Vaccines (Basel). 2020. PMID: 32486350 Free PMC article.
-
Vaccination status, acceptance, and knowledge toward a COVID-19 vaccine among healthcare workers: a cross-sectional survey in China.Hum Vaccin Immunother. 2021 Nov 2;17(11):4065-4073. doi: 10.1080/21645515.2021.1957415. Epub 2021 Aug 3. Hum Vaccin Immunother. 2021. PMID: 34344260 Free PMC article.
-
Willingness of the general population to accept and pay for COVID-19 vaccination during the early stages of COVID-19 pandemic: a nationally representative survey in mainland China.Hum Vaccin Immunother. 2021 Jun 3;17(6):1622-1627. doi: 10.1080/21645515.2020.1847585. Epub 2021 Feb 19. Hum Vaccin Immunother. 2021. PMID: 33606600 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical